Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity
US10072010B2 · kind B2 · utility
45Cited by
21References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2017 |
| Grant date | Sep 11, 2018 |
| Priority date | — |
| Expiry date | Jun 21, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]-quinoxaline compounds, represented by Formula 1, defined herein, free base or pharmaceutically acceptable salt forms of the compounds, pharmaceutical compositions thereof, and methods of treating conditions of the central nervous system therewith:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.